Ideal combination of better coverage for less cost is possible
OTTAWA, April 19, 2018 – HEAL – Organizations for Health Action – applauds the House of Commons Health Committee on the release of its long-awaited report on the feasibility of a national pharmacare program. After two years and nearly 100 expert witnesses, the report lays the groundwork for filling a longstanding gap in the Canadian healthcare system.
“Our members applaud the committee for their tireless work on this important subject,” said Ondina Love, HEAL Co-Chair and CEO of the Canadian Dental Hygienists Association. “HEAL supports a move towards a pan-Canadian pharmacare program working in concert with federal, provincial and territorial governments to improve access for the millions of Canadians currently going without the pharmaceuticals that they need. This is also an opportunity to bring down costs by bringing to bear the entire purchasing power of a country the size of Canada.”
“This is a great step forward and provides valuable guidance to the recently-established working group under Dr. Eric Hoskins,” added Francois Couillard, HEAL Co-Chair and CEO of the Canadian Association of Medical Radiation Technologists. “HEAL and all of our 40 members look forward to engaging with Dr. Hoskins’ advisory committee in the year to come as it develops its recommendations to the federal government on its approach to pharmacare. Prescription drug coverage has been a gap in our publicly-funded universal healthcare system for too long, and this is a great opportunity to start closing that gap.”
HEAL is a coalition of national health organizations that represents a cross-section of health providers, health regions, institutions, and facilities. All of HEAL’s members are dedicated to protecting and strengthening Canada’s health system, and these organizations represent more than 650,000 health-care providers from across the country.
For more information, please contact: